Evidence map›Paper›PMID 42830368›Full record

ArticleJournal of medical systems2026

Development and Nationwide Multicentre Evaluation of Guideline-Grounded Large Language Model Chatbots to Support Patient Self-Management and Education in Rheumatology.

Tim Wilhelmi, Vanessa Bartsch, Marius Platt, Asarnusch Rashid, Johannes Hornig, Martin Krusche, Axel J Hueber, Daniel Fink, Alexander Pfeil, Gabriel Dischereit and 12 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of medical systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Tim Wilhelmi *Department of Rheumatology, Clinical Immunology, Osteology and Physical Medicine, Justus Liebig University Giessen, Campus Kerckhoff, Bad Nauheim, Germany.ORCID http://orcid.org/0009-0008-2400-2840
Vanessa Bartsch *Division of Rheumatology, Paracelsus Medical University, Klinikum Nürnberg, Nürnberg, Germany.ORCID http://orcid.org/0000-0001-6029-2103
Marius PlattSchool of Medicine, Institute for Digital Medicine, Philipps-Universität Marburg, Marburg, Germany.
Asarnusch RashidZentrum für Telemedizin, Bad Kissingen, Germany.
Johannes HornigRheumapraxis an der Hase, Osnabrück, Germany.
Martin KruscheDivision of Rheumatology, III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Axel J HueberDivision of Rheumatology, Paracelsus Medical University, Klinikum Nürnberg, Nürnberg, Germany.
Daniel FinkRheumazentrum Mittelhessen, Bad Endbach, Germany.
Alexander PfeilCenter of Rheumatology and Section Rheumatology and Osteology, Department of Internal Medicine III, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.
Gabriel DischereitMVZ Frankenberg, Frankenberg, Germany.
Marie-Therese HolzerDivision of Rheumatology, III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ulrich DrottDeutsches Endokrinologisches Versorgungszentrum, Frankfurt, Germany.
Peer AriesDepartment of Rheumatology, Immunologikum, Hamburg, Germany.
Max MüllerDeutsche Rheuma-Liga e.V, Bonn, Germany.
Peter BöhmDeutsche Rheuma-Liga e.V, Bonn, Germany.
Harriet MorfDepartment of Medicine 3 - Rheumatology and Immunology, Friedrich- Alexander- Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
Hannah LabinskyDepartment of Internal Medicine 2, Rheumatology/Clinical Immunology, University Hospital Würzburg, Würzburg, Germany.
Felix MühlensiepenCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Germany.
Diego BenaventRheumatology Department, Hospital Universitari de Bellvitge, Barcelona, Spain.
Sebastian KuhnSchool of Medicine, Institute for Digital Medicine, Philipps-Universität Marburg, Marburg, Germany.
Philipp Klemm *Department of Rheumatology, Clinical Immunology, Osteology and Physical Medicine, Justus Liebig University Giessen, Campus Kerckhoff, Bad Nauheim, Germany.ORCID http://orcid.org/0000-0001-7911-4235
Johannes Knitza *School of Medicine, Institute for Digital Medicine, Philipps-Universität Marburg, Marburg, Germany. knitza@uni-marburg.de.ORCID http://orcid.org/0000-0001-9695-0657

Funding

Horizon Europe grant for the SPIDERR project 101080711
6 · The paper itself

Abstract

Patients with rheumatic diseases have persistent information needs that are not fully addressed in routine care. We developed and evaluated guideline-grounded, large language model (LLM) chatbots to support patient self-management and education in rheumatology.Ten disease-specific chatbots based on German guidelines were co-developed and deployed through 13 rheumatology centres and six patient organisations. Chatbot users rated responses and completed a questionnaire. User questions, feedback, and response characteristics were analysed using category-based coding and a six-dimensional LLM-as-a-judge assessment, with LLM-based ratings compared with rheumatologist ratings in random subsets.Between September 2025 and January 2026, 6291 questions were recorded. Thirteen question categories were identified, most commonly disease-specific questions (50.2%), medication and monitoring (37.3%) and diagnostics (28.2%). The chatbots were unable to answer in 263 interactions (4.2%). Of 2671 responses rated by users, 2481 (92.9%) received a positive rating. Insufficient detail was the most common reason for negative ratings (125/190, 65.8%). Among 602 questionnaire respondents, 84.6% reported that the chatbot was easy to use, 84.1% that answers were easy to understand, and 80.2% that it was a useful addition to patient education. In the LLM-based evaluation, 95.3% of answers were rated as completely safe and 79.1% as completely correct. Guideline adherence was assessed separately, with 45.0% rated as fully adherent; agreement with physician assessment was weak.Guideline-grounded chatbots received predominantly positive user feedback in real-world use, while LLM-based evaluation suggested that most responses were safe and correct. User questions and feedback may help guide iterative improvements to source content and patient education materials. Further studies are needed to evaluate educational effectiveness and independently validate response quality and clinical safety.

Indexed as

Patient Education as TopicRheumatic DiseasesRheumatologySelf-ManagementAdultFemaleGermanyHumansLarge Language ModelsMaleMiddle AgedSurveys and QuestionnairesArtificial intelligenceChatbotsLarge language modelsPatient educationRetrieval-augmented generationRheumatology

Identifiers

PMID42830368
PMCPMC13635029

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.